The Effectiveness of Group Schema Therapy in the Treatment of Borderline Symptoms in Adolescents
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15-18
SponsorTurku University Hospital
About this trial
The goal of this randomized and controlled trial is to assess the effectiveness of group schema therapy in the treatment of adolescents with borderline symptoms. The intervention utilizes self-recorded video material as an experiential method. The intervention comprises 30 group sessions and 8 individual sessions. Additionally, there are group sessions for the participants' parents. Participants in the control group receive treatment as usual.
Eligibility criteria
Qualifiers
The participant fulfills at least three diagnostic criteria for borderline personality disorder as assessed by means of the SCID-II structured clinical interview
The participant and the participant's parent(s) are able to commit to the research protocol for the entire duration of the study
The participant is able to participate in a research intervention in Finnish and fill out the study questionnaires in Finnish
Disqualifiers
The participant currently has psychotic symptoms or a serious risk of suicide
The participant has been diagnosed with an intellectual disability or an autism spectrum disorder
The main clinical diagnosis of the participant is a substance abuse disorder or substance use would endanger commitment to the research intervention
The participant has another illness or symptom that endangers the participant's ability to complete the study
Trial design
Treatments tested in this trial
- Group schema therapy
- Treatment as Usual (TAU)
Treatment groups
64 Participants
are divided into 2 treatment groupsSponsors and collaborators
Turku University Hospital
Lead sponsor
University of Turku
Collaborator
Source ClinicalTrials.gov